Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18022189 | 1.00 | LMNA (0.35) | LMNAABCB11PTGS1ALDH1A1CYP1A2 | |
| SCHEMBL18023679 | 1.00 | LMNA (0.35) | LMNAABCB11PTGS1ALDH1A1CYP1A2 | |
| SCHEMBL18022151 | 0.85 | CYP3A4 (0.51) | LMNAPTGS1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL18022139 | 0.85 | CYP3A4 (0.51) | LMNAPTGS1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17441601 | 0.82 | — | — | |
| SCHEMBL17826336 | 0.80 | MAPT (0.33) | LMNAABCB11PTGS1CYP3A4CYP2C19 | |
| SCHEMBL18022145 | 0.80 | ALDH1A1 (0.43) | LMNAPTGS1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL18022156 | 0.78 | LMNA (0.42) | LMNAALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL18034094 | 0.78 | LMNA (0.42) | LMNAALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL13757620 | 0.76 | LMNA (0.38) | LMNAABCB11PTGS1ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2958883-B1 | CYCLOHEXENONE COMPOSITIONS AND PROCESS FOR MAKING THEREOF | GOLDEN BIOTECHNOLOGY CORP (US) | 2019-01-30 | — | — | EP | disclosed |
| US-20160251308-A1 | Cyclohexenone Compositions and Process for Making Thereof | GOLDEN BIOTECHNOLOGY CORP (US) | 2016-09-01 | — | — | US | disclosed |
| US-20160251308-A1 | Cyclohexenone Compositions and Process for Making Thereof | GOLDEN BIOTECHNOLOGY CORP (US) | 2016-09-01 | — | — | US | disclosed |
| WO-2016133940-A1 | ANTICANCER AGENTS AND PROCESS OF MAKING THEREOF | GOLDEN BIOTECHNOLOGY CORPORATION (US) | 2016-08-25 | — | — | WO | disclosed |
| US-20160237012-A1 | ANTICANCER AGENTS AND PROCESS OF MAKING THEREOF | GOLDEN BIOTECHNOLOGY CORPORATION | 2016-08-18 | — | — | US | disclosed |
| US-20160237012-A1 | ANTICANCER AGENTS AND PROCESS OF MAKING THEREOF | GOLDEN BIOTECHNOLOGY CORPORATION | 2016-08-18 | — | — | US | disclosed |
| US-9365481-B2 | Cyclohexenone compositions and process for making thereof | GOLDEN BIOTECHNOLOGY CORPORATION (US) | 2016-06-14 | — | — | US | disclosed |
| US-9365481-B2 | Cyclohexenone compositions and process for making thereof | GOLDEN BIOTECHNOLOGY CORPORATION (US) | 2016-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160237012-A1 | ANTICANCER AGENTS AND PROCESS OF MAKING THEREOF | MCL1, HCCS, CASP3 | LMNA 1228/4885ABCB11 2453/4885PTGS1 2173/4885 |
| US-20160251308-A1 | Cyclohexenone Compositions and Process for Making Thereof | HSD17B7, CYP17A1, CYP51A1 | LMNA 379/4885ABCB11 3131/4885PTGS1 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.